What is the intrinsic value of HRMY?

As of 2025-12-22, the Intrinsic Value of Harmony Biosciences Holdings Inc (HRMY) is 54.98 USD. This HRMY valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 37.81 USD, the upside of Harmony Biosciences Holdings Inc is 45.40%.

The range of the Intrinsic Value is 41.15 - 92.95 USD

Is HRMY undervalued or overvalued?

Based on its market price of 37.81 USD and our intrinsic valuation, Harmony Biosciences Holdings Inc (HRMY) is undervalued by 45.40%.

	Range	Selected	Upside
a
DCF (Growth 5y)	41.15 - 92.95	54.98	45.4%
DCF (Growth 10y)	45.89 - 98.89	60.18	59.2%
DCF (EBITDA 5y)	36.14 - 52.17	39.88	5.5%
DCF (EBITDA 10y)	41.20 - 59.48	46.18	22.1%
Fair Value	80.59 - 80.59	80.59	113.14%
P/E	43.32 - 101.21	69.58	84.0%
EV/EBITDA	35.32 - 53.32	38.54	1.9%
EPV	32.41 - 41.54	36.98	-2.2%
DDM - Stable	29.47 - 96.96	63.22	67.2%
DDM - Multi	27.76 - 71.41	40.02	5.9%